BALDUZZI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 5.693
EU - Europa 2.673
AS - Asia 2.422
SA - Sud America 393
AF - Africa 67
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.258
Nazione #
US - Stati Uniti d'America 5.586
GB - Regno Unito 918
SG - Singapore 773
CN - Cina 569
IT - Italia 446
HK - Hong Kong 313
VN - Vietnam 304
BR - Brasile 303
SE - Svezia 267
DE - Germania 218
IE - Irlanda 172
FI - Finlandia 123
FR - Francia 108
RU - Federazione Russa 97
UA - Ucraina 90
IN - India 67
KR - Corea 67
TR - Turchia 54
CA - Canada 53
ID - Indonesia 52
NL - Olanda 40
BD - Bangladesh 36
BG - Bulgaria 36
MX - Messico 35
AR - Argentina 34
JP - Giappone 31
BE - Belgio 24
PL - Polonia 22
ZA - Sudafrica 22
PK - Pakistan 18
ES - Italia 16
AT - Austria 15
IQ - Iraq 15
CL - Cile 14
PH - Filippine 14
AE - Emirati Arabi Uniti 12
EC - Ecuador 12
GR - Grecia 12
MY - Malesia 12
LT - Lituania 11
JO - Giordania 9
MA - Marocco 9
MK - Macedonia 9
NP - Nepal 9
UZ - Uzbekistan 9
CO - Colombia 8
CZ - Repubblica Ceca 8
KE - Kenya 8
VE - Venezuela 8
CH - Svizzera 7
IL - Israele 7
TH - Thailandia 7
AU - Australia 6
DK - Danimarca 6
BH - Bahrain 5
CY - Cipro 5
DZ - Algeria 5
IR - Iran 5
OM - Oman 5
PY - Paraguay 5
RO - Romania 5
TN - Tunisia 5
BO - Bolivia 4
CR - Costa Rica 4
PE - Perù 4
SA - Arabia Saudita 4
BN - Brunei Darussalam 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
MD - Moldavia 3
NO - Norvegia 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BW - Botswana 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LY - Libia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
Totale 11.240
Città #
Southend 661
Fairfield 582
Ashburn 561
Singapore 529
Santa Clara 482
Woodbridge 327
Chandler 311
Hong Kong 306
Houston 233
Seattle 215
San Jose 213
Ann Arbor 192
Wilmington 176
Dublin 171
Beijing 163
Dearborn 162
Cambridge 160
Nyköping 147
Jacksonville 127
London 106
Hefei 103
Chicago 102
Hanoi 93
New York 90
The Dalles 89
Helsinki 86
Los Angeles 85
Ho Chi Minh City 84
Modena 75
Council Bluffs 70
Dallas 54
San Diego 52
Seoul 49
Bologna 39
Jakarta 39
Milan 39
Lauterbourg 37
Munich 37
Shanghai 37
Princeton 35
Moscow 34
Sofia 34
São Paulo 33
Eugene 32
Boardman 28
Redwood City 28
Salt Lake City 28
Elk Grove Village 23
Frankfurt am Main 23
Phoenix 23
Izmir 22
Brussels 20
Buffalo 20
Columbus 20
Rome 20
Tampa 20
Bremen 19
Warsaw 19
Fremont 18
Orem 18
Tokyo 18
San Francisco 17
Turin 17
Mexico City 15
Montreal 14
Sterling 14
Dong Ket 13
Norwalk 13
Brooklyn 12
Haiphong 11
Toronto 11
Paris 10
Redondo Beach 10
Reggio Emilia 10
Hillsboro 9
Ottawa 9
Seongnam 9
Turku 9
Atlanta 8
Da Nang 8
Istanbul 8
Rio de Janeiro 8
Tilburg 8
Amman 7
Amsterdam 7
Biên Hòa 7
Brasília 7
Buenos Aires 7
Chennai 7
Cleveland 7
Johannesburg 7
Lappeenranta 7
Nagoya 7
Nanjing 7
Stockholm 7
Tashkent 7
Changchun 6
Denver 6
Des Moines 6
Dhaka 6
Totale 7.977
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 478
Non-steroid agents for idiopathic pulmonary fibrosis 456
Indicators of Complex Care During the Consultation-Liaison Psychiatry Activity at the Transplant Center of the Policlinico Hospital, Modena 433
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 405
The impact of shift work on the psychological and physical health of nurses in a general hospital: a comparison between rotating night shifts and day shifts 401
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 396
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 378
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 365
Short-term and long-term effects of tibolone in postmenopausal women 358
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 356
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 344
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 342
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 335
"the More the Better" Paradox of Antenatal Ultrasound Examinations in Low-Risk Pregnancy 333
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 328
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 294
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 294
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 292
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 288
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 283
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 280
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 279
Trastuzumab containing regimens for early breast cancer. 276
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 269
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 266
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 264
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 263
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 257
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 255
Short and long term effects of tibolone in postmenopausal women 241
Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study 231
Trastuzumab-containing regimens for metastatic breast cancer 227
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 224
Erlotinib for advanced pancreatic cancer 177
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 163
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 159
Outpatient parents' views on shared-decision-making at an Italian children's hospital 150
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 133
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial. 38
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial. 28
Totale 11.339
Categoria #
all - tutte 40.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 0 115 44
2021/2022819 46 47 97 43 27 49 33 57 91 82 157 90
2022/20231.033 95 123 72 92 94 100 26 94 261 13 18 45
2023/2024622 21 28 46 53 103 59 80 63 23 39 43 64
2024/20251.858 57 25 38 110 371 321 148 117 170 76 179 246
2025/20263.409 235 101 260 377 654 244 518 202 369 390 59 0
Totale 11.339